The preprint of the UK variant study suggests vaccine efficacy is maintained with Pfizer which is good.
The news out of South Africa is less positive, I think we might be at or close to seeing vaccine escape here.
So yes... the study which was publicly released today from Pfizer/Biontech evidences their vaccine is still highly effective again the B117 mutation. This is the dominant strain of the virus currently in the UK. I had seen further studies from other scientists indicating that there may be a small reduction in efficacy, somewhere potentially in the region of 5-15% (although it’s impossible to tell at this point) but the vaccines are still highly effective and rollout should continue as planned. Because Pfizer/Biontech is effective against this, it is also likely oxford and Moderna will also be.
There are 2 strains we need to be concerned about. The Brazil strain and the South African variant. What is so key about these two strains which make them different to the Kent variant? Well they contain a mutation in genetic code at position 484, or a mutation known as E484K. This mutation is potentially what could evade the vaccine and lead to antibody escape.
The hope is at the moment, these two variants of concern will not render the vaccine pointless, however may reduce efficacy substantially. Vaccines have to be over 50% effective as a bare minimum to be approved by the regulatory authorities. If the mutations were to see a 30-40% reduction in efficacy from our approved vaccines, then we would encounter issues (also remember oxford averages to only 70% effective).
The good news is, if this is the case and the mutations do evade the vaccines, new vaccines could potentially be designed and produced in up to 4 weeks and emergency authorisation immediately administered. The real issue here though is that all of the vaccines already manufactured become of less use and you essentially have to start back at square one revaccinating your population.
We can currently see massive spikes in Portugal and Spain, most likely the Brazil variant. South Africa has reported significant cases of reinfection from the new variant (although remember we don’t know how long antibodies last anyway). The SA variant has been identified in Germany and also we had 2 cases recently identified in the uk... it hasn’t been confirmed whether this led to any further transmission. In a theoretical scenario, if we could keep these variants out through border control and roll out our current vaccine program, then we may reach herd immunity through vaccination. However it is very possible these variants are already spreading in the uk. A big worry of mine is the SA strain is currently spreading like wildfire in South Africa- even though it is summer there(potentially means a higher transmissibility).
Anyway, rambling over, we just need to wait and see what the conclusion from trials is on the 2 variants with the genetic changes and then we will have to go from there.